Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thermal Ablation + Chemotherapy in Hepatic Oligometastatic PDAC
NCT05611359Not yet recruiting
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Jan 2023
- Primary completion
- Dec 2026
01
Overview
Randomised, open-label trial (2 arms), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Primary endpoint: Overall Survival at 2 years. Planned start Jan 2023; status: not yet recruiting.
Beyond the preview
Go deeper on NCT05611359.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05611359.